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Exosome is an extracellular vesicles (EVs) that have become a 
rising interest for the past decade due to its important role in 
intercellular communications as well as containing biological 
molecules such as genetic materials and proteins that can be used as 




found in detecting and analyzing the nano-sized extracellular vesicles. 
Other conventional known methods to detect and analyze EVs require 
complex experimental procedures, and it is time-consuming.  In this 
study, we present an interdigitated electrode (IDE) impedance-based 
biosensor that detects the captured EVs through impedance 
measurement. The impedance of the captured EVs was 1.06 kΩ and 
has increased to 16.14 kΩ after EVs were captured onto the fabricated 
biosensor. The impedance further increased to 19.33 kΩ as anti-CD63 
conjugated gold nanoparticles were bound onto the captured EVs. This 
shows that the additional binding of the gold nanoparticle has enhanced 
the sensitivity of the impedance. Therefore, the proposed impedance-
based biosensor with the application of surface modified gold 
nanoparticles shows a promising platform that is capable to detect 
extracellular vesicles as a diagnostic tool in clinical application. 
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Chapter 1. Introduction. 
 
Exosomes are small extracellular vesicles with a size of 30-
150nm that have increased in their interest over the past decade [1]. 
Exosomes are released from all eukaryotic cells. They were recently 
found to play an important role in intercellular communication and 
carry various active biological molecules such as proteins, lipids, 
nucleic acids, mRNAs, and microRNAs shown in Figure 1. Because of 
the specific biological molecules that exosomes contain, it enables 
researchers to track down the origin cell of where the exosomes 
were released. This unique characteristic property of exosome 
suggests the potential of using exosome as a biomarker to diagnose 
various diseases such as cardiovascular diseases, neurodegenerative 
diseases, different types of tumors, and other more [2-5]. However, 
isolating and efficiently measuring the detection of small size and low 
dense of exosomes remain a challenge. The current known 
conventional methods of detecting and analyzing exosomes are time-
consuming and require complex experimental procedures [6, 7]. 
Regardless of its challenges, various diagnostic tools [5, 8-13] and 
methods are being researched, such as optically [14-16], 
electrically [17, 18], and mechanically [19-21] to detect 
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biomaterials like exosomes. 
Electrochemical impedance spectroscopy (EIS) is one of the 
electrical methods that is a widely integrated analytical tool to detect 
and quantify targeting molecules of interest. Unlike other methods 
such as potentiometry and amperometry, EIS does not necessarily 
need a redox probe, which makes this method a fast and simple 
detecting method as well as less complex in the sensor fabrication 
process. Therefore, EIS makes it a suitable and promising technique 
to apply in the biomedical point-of-care test [22-24]. The 
impedance is an input of a small sinusoidal voltage, in which the 
resulting current is computed as a function of frequency [25, 26]. 
Therefore, by the electrode surface alternation and through the 
binding of biomolecules, a measurable interfacial impedance changes 
as it is induced [24, 27]. The sensitivity of the sensor is determined 
by the electrode gap width and the electric field strength that is 
generated between the electrodes [28]. The integration of the gold 
nanoparticles (AuNPs) can also improve the sensitivity of the EIS 
sensor [29].  
In this research, an EIS biosensor was fabricated for the 
selective and label-free detection of exosomes derived from plasma. 
In addition, binding of the anti-CD63, an exosome marker protein, 
conjugated AuNPs took place to enhance the detecting sensitivity of 
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the exosomes. The selectively captured exosomes and the binding of 
the anti-CD63 conjugated AuNPs were then analyzed through 
impedance measurement to observe the change in its impedance. 
Figure 2 shows an illustration of the overall scheme of the 
interdigitated electrode (IDE) impedance-based biosensor with 































Figure 2. The overall schematic illustration of the interdigitated 









N-hydroxysuccinimide (NHS), (3-aminopropyl)triethoxysilane 99% 
(APTES), mercaptopoly(ethylene glycol) carboxylic acid (thiol-
PEG-carboxylate, average Mn 2,100), sodium citrate dehydrate 
(C6H5Na3O7·2H2O), and tetrachloroauric (III) acid (HAuCl4·3H2O), 
11-mercaptoudecanoic acid 95% (11-MUA) were all purchased at 
Sigma-Aldrich (St. Louis, MO). N-Ethyl-N ’ -(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC) and 
Albumin Bovine Fraction V (BSA) were purchased from MP 
Biomedicals (Illkirch, Santa Ana, CA). 
Bis(sulfosuccinimidyl)suberate (BS3) was purchased from Thermo 
Scientific (Rockford, IL). The anti-CD63 antibody and lyophilized 
exosomes from plasma of healthy donors were purchased at 
HansaBiomed Life Science (Tallin, Estonia). Phosphate buffer saline 
(PBS) was purchased from Welgene (Gyeongsangbuk-do, Korea). 
For all sample preparation was prepared through ultrapure water 




2.2. Gold Nanoparticle Synthesis 
 
Gold Nanoparticles synthesis was prepared based on the slightly 
modified standard citrate reduction process [30]. Briefly, an aqueous 
solution of 1 mM of HAuCl4 was prepared and was heated with gentle 
stir until it was brought to boil. With a constant stirring and heating 
of the tetrachloraurate solution, 1% (v/v) of sodium citrate dehydrate 
was quickly added. After stirring for approximately for 10 min, the 
solution gradually changed its color to wine red from pale yellow. 
Then the solution was placed at room temperature to cool down after 
15 min of reflux. Then it was stored at 4℃ for further use.  
 
2.3. Conjugation of Anti-CD63 on Gold Nanoparticles 
 
The schematic illustration of the preparation of anti-CD63 
conjugated gold nanoparticle steps is shown in Figure 3. The gold 
nanoparticle surface was modified using 10mM of thiol-PEG-
carboxylate. After preparing the 10 mM solution of thiol-PEG-
carboxylate, it was then added to the 500 μL of the gold nanoparticle 
solution. It was incubated for 8 h at 4℃ to activate the reaction. 
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Afterward, thiol-PEG-carboxylate modified gold nanoparticles were 
washed and centrifuged twice at 8000g for 40 min at 4℃ (Gyrozen, 
Seoul, Korea) to remove excess thiol-PEG-carboxylate that were 
not activated. Following the removal of excess thiol-PEG-
carboxylate, 100 mM of EDC and NHS were added to the PEG-
carboxylate modified gold nanoparticle solution at a 1:1 ratio and 
were left to activate the reaction for 2 h at room temperature. Then 
again, the removal of excess EDC and NHS was proceeded by 
washing and centrifugation at 8000g for 40 min at 4℃. Then after 
EDC/NHS activated, gold nanoparticles were resuspended with PBS 
after centrifugation. Then 10 μg/mL of anti-CD63 was added and 
incubated overnight at 4℃. After incubation, 1% (w/v) BSA was 
added and incubated for 2 h for the blocking buffer to saturate excess 
protein-binding sites. The solution was then washed with PBS and 











Figure 3. Schematic diagram of anti-CD63 conjugation onto the gold 
nanoparticles. Surface modification on the synthesized gold 
nanoparticles using thiol-PEG-carboxylate. The EDC/NHS 
activation and conjugation of anti-CD63 on the gold nanoparticles. 




2.4. Sensor Fabrication 
 
 The Interdigitated electrode (IDE) sensor was fabricated using a 
standard photolithographic nano/microfabrication technique. 
Deposition and photolithographic patterning were done on bi-layers of 
Cr (10 nm)/Au (200nm) deposited on a cleanly prepared silicon wafer. 
After the fabrication of the gold interdigitated electrode sensor, 100 
μm thick SU8-50 electrode encapsulation well was fabricated on the 
electrode. There are 23 pairs of interdigitated electrodes with 60 μ
m of spacing in between the electrodes. The self-assembly 
monolayer of 5 mM of 11-MUA was activated onto the interdigitated 
gold electrode surface for overnight to prevent the electrode surface 
contamination from large debris from non-specific binding during the 
steps of exosome immobilization shown in Figure 4a. Then, the 
electrodes were washed with ultrapure water. 
 
2.5. Sensor Surface Modification 
 
 The hydroxyl group was activated in between the electrode using 
oxygen plasma (60 W, 80 sccm O2) for 10 min. Afterward, the 
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electrodes were immersed in 5% (v/v) APTES at room temperature 
for an hour. It was then washed with ethanol and was placed on a 
hotplate at 100℃ for 30 min. Then freshly prepared 20 mM BS3 
(amine to amine crosslinker) was prepared in ethanol solution and 
activated onto the electrode for 30 min at room temperature. 
Following the BS3 activation, 10 μg/mL of anti-CD63 was treated 
onto the activated electrodes and was incubated for 3 h at 4℃. After 
the incubation of anti-CD63, 5 μg/mL (2.5 x 1010 vesicles/mL) of 
the plasma-derived exosomes were drop-casted onto the electrode 
and were incubated in 4℃ for 30 min. Then the electrodes were 
washed with PBS to remove any unbound exosomes. Then anti-
CD63 conjugated gold nanoparticles were added and incubated 
overnight at 4℃. The sensor was then washed with ultrapure water 
to remove any unbound anti-CD63 conjugated gold nanoparticles. 
Before the immobilization of the exosomes, impedance was measured 
after each step when the surface modification was made, shown in 











Figure 4. 11-mercaptoudecanoic acid (11-MUA) activation. (a) 
Schematic illustration of self-assembly monolayer of 5 mM of 11-
MUA on the electrode surface. (b) Bode plot of impedance and phase 




Chapter 3. Results and Discussion 
 
3.1. Characterization of Anti-CD63 Conjugated Gold 
Nanoparticles 
 
 The hydrodynamic diameter and zeta-potential of anti-CD63 
conjugated gold nanoparticles were examined using a dynamic light 
scattering (Zetasizer Nano-ZS, Malvern Panalytical). The 
morphology and size determination were then characterized using a 
high-resolution transmission electron microscope (JEM3010, JEOL) 
with 300 kV of acceleration voltage. The sample preparation for HR-
TEM was prepared on a thin carbon film-coated copper grid (300 
mesh). UV-Visible spectroscopic measurement was acquired using 
a single beam spectrophotometer (Lambda 35 UV/VIS Spectrometer, 
PerkinElmer). 
 
3.2. UV-Visible Spectrophotometry 
 
 The determination of the anti-CD63 conjugated gold nanoparticle 
solution took place through the optical technique of UV-visible 
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spectrophotometer, one of the important methods for characterizing 
colloidal gold nanoparticles. This optical method indicates the 
nanoparticle size distribution range through the width of the 
absorption spectra. It is known that the conventional citrate reduction 
method prepared gold nanoparticles to have the absorption peak that 
is observed at around 520 nm, which corresponds to the typical 
surface plasmon resonance (SPR)[31]. In this experiment, UV-vis 
spectra were measured between the 400 – 700 nm. Figure 5 shows 
the measured absorption peaks of three prepared samples, which are 
control colloidal gold nanoparticles, thiol-PEG-carboxylate modified 
gold nanoparticles, and anti-CD63 conjugated gold nanoparticles. In 
this study, the control colloidal gold nanoparticles' absorption peak 
was observed to be 524 nm. Then the absorption peak of anti-CD63 
conjugated gold nanoparticles has shifted to 527 nm due to the 
presence of the thiol-PEG-carboxylate capsulation and the binding 



























Figure 5. Characterization of anti-CD63 conjugated gold nanoparticles 
through UV-visible spectrophotometer.  UV-visible spectra of 
control gold nanoparticle (AuNP), thiol-PEG-carboxylate modified 




3.3. Zeta Size and Zeta-Potential 
 
 The mean hydrodynamic diameter and the zeta-potential of the 
control colloidal gold nanoparticles, thiol-PEG-carboxylate capped 
gold nanoparticles, and anti-CD63 conjugated gold nanoparticles 
were evaluated. The mean hydrodynamic diameter of the control 
colloidal gold nanoparticle was to be 23 nm, which shows a larger 
value compared to HR-TEM in Figure 6. This is because compared 
to the dried state prepared gold nanoparticles in HR-TEM, the 
solution state of gold nanoparticles is affected by the presence of the 
double layer in the calculation of the hydrodynamic radius in the DLS 
measurement [31]. The zeta-potential measurement of control 
colloidal gold nanoparticles and anti-CD63 conjugated gold 
nanoparticles were negatively charged, as shown in Table 1. The 
control colloidal gold nanoparticles had a zeta-potential of -35 mV, 
and then it increased to -22 mV for anti-CD63 conjugated gold 
nanoparticles. Knowing that the zeta-potential is affected by the 
thickness of the electrical double layer, that is, the electrical charge 
of the layer and the dielectric constant, it can be confirmed that the 












 AuNP AuNP.PEG AuNP.Ab 
Hydrodynamic 
Diameter 
23.12 nm 28.68 nm 30.29 nm 
Zeta-Potential -35.8 mV -34.7 mV -22.9 mV 
 
Table 1. Hydrodynamic diameter and zeta-potential measurement 




3.4. High-Resolution Transmission Electron 
Microscopy, Transmission Electron Cryomicroscopy, 
and Fluorescence Microscopy 
 
 The use of high-resolution transmission electron microscopy 
took place to examine the size and the morphology of the synthesized 
gold nanoparticles and transmission electron cryomicroscopy was 
used to examine the exosomes. Figure 6a is an image of a control 
gold nanoparticle without any conjugation. Since the surface of the 
gold nanoparticles were not treated, the nanoparticles are not spread 
evenly. However, after the conjugation of anti-CD63 on the gold 
nanoparticles, it spread uniformly and orderly compared to the 
control colloidal gold nanoparticles with an average size of 20 nm 
shown in Figure 6b. Then, anti-CD63 conjugated gold nanoparticles 
were added to a solution with exosome shown in Figure 6d. As shown 
in Figure 6c, the anti-CD63 conjugated gold nanoparticles were well 
attached around the exosomes. The result of anti-CD63 conjugation 
onto the gold nanoparticles, the electrical double layer repulsive 
forces were formed around the conjugated gold nanoparticles 
preventing nanoparticles to agglomerate. Therefore, it can be 
confirmed that the anti-CD63 has been conjugated onto the gold 
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nanoparticle surface [31]. Then, characterization of fluorescence 
microscopy took place on the sensor surface as exosomes were 
immobilized. As shown in Figure 7b and c, it shows clear that the 







Figure 6. Image of high resolution-transmission electron microscopy 
(HR-TEM). (a) Citrate reduction prepared gold nanoparticle 
(control). (b) Anti-CD63 conjugated gold nanoparticles (c) Anti-
CD63 conjugated gold nanoparticles bound to exosomes. (d) 








Figure 7. Image of fluorescence microscopy of immobilized exosomes. 
(a)Bright field image of sensor electrode with exosome. (b) Dark 
field image of sensor electrode with exosome (c) fluorescence image 









3.5. Impedance Measurement 
 
 The impedance spectral measurements were carried out using 
Electrochemical Workstation (CHI614E, CH Instruments Inc.). The 
magnitude and phase of the impedance data were collected in the 
frequency range of 1 Hz to 100 kHz and by applying a voltage of 5 
mV at room temperature. The baseline control measurement was 
performed using only PBS. Following control measurement, the 
impedance was measured after each step of immobilizing exosomes 
and binding of anti-CD63 conjugated gold nanoparticles onto the 
immobilized exosomes. To prevent unspecific binding and 
contamination of the electrode during the substrate surface 
modification steps, a monolayer of 11-MUA was self-assembled on 
the electrode, and impedance was measured, which is shown in 
Figure 4b. The magnitude of the impedance shows little to no change, 
yet the impedance phase component has shifted downward. This 
indicates an ideal result showing that the 11-MUA does not affect 
much change in the impedance magnitude and does not interfere with 
the impedance during the immobilization of the exosomes and binding 
of the anti-CD63 conjugated gold nanoparticles. The phase 
component of the impedance shifted downwards due to the capacitive 
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layer effect on the 11-MUA treated electrode [29]. After self-
assembling a monolayer of 11-MUA, the substrate surface was 
modified to immobilize anti-CD63, and impedance was measured 
after each step of the substrate modification as shown in Figure 8a. 
The magnitude of the impedance has induced slightly. The phase has 
shifted further to the lower frequency due to its capacitive effect as 








Figure 8. Sensor surface modification scheme and impedance 
measurement. (a) Bode plot of impedance and phase magnitude of 
surface modification steps of immobilizing anti-CD63. (b) Schematic 
illustration of immobilizing anti-CD63 on the substrate. 
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3.6. Equivalent Circuit Model and Analysis for 
Impedance Components 
 
EIS's is one of the techniques that applies alternating current (AC) 
signal, a small amplitude voltage. Then the AC voltage signal scans a 
wide range of frequencies [25, 26]. The sensor is non-faradaic 
electrochemical impedance spectroscopy. It does not require the use 
of redox couples and a reference electrode. The mechanism of the 
non-faradaic EIS sensor of the absence and presence of the 
exosomes and anti-CD63 conjugated gold nanoparticles effect in the 
impedance is illustrated through the equivalent circuit model in Figure 
9 [29, 32]. Before the immobilization of the exosomes, the equivalent 
circuit model contains only the double-layer capacitance of the 
electrodes (Cdl) in a series with the resistance of the base solution 
of PBS (Rsol). The electrodes are capsulated with a thin layer of 
charges as PBS is placed on the electrodes for control measurement, 
which makes a double layer capacitance on the electrode (Cdl) shown 
in Figure 9 [33]. Then, the addition of an impedance (Zg) is added to 
the series of the equivalent circuit when the exosomes and anti-
CD63 conjugated gold nanoparticles are added which the impedance 
(Zg) contains the parallel of the exosomes and anti-CD63 conjugated 










Figure 9. Equivalent Circuit Model. Illustration of the principles of the 
equivalent circuit of the electrochemical impedance spectroscopy 
before and after the immobilization of the exosomes and anti-CD63 




3.7. Impedance Measurement of Exosomes and anti-
CD63 Conjugated Gold Nanoparticles 
 
The sensitivity of the impedance biosensor is affected as the 
surface of the sensor is modified with biomolecules, such as 
exosomes. When the exosomes were immobilized, the impedance 
change can be seen in the frequency range of 1 Hz to 10 kHz 
detecting 2.5 x 1010 vesicles/mL. The bode plot of before and after 
the immobilized exosomes and anti-CD63 conjugated gold 
nanoparticles are plotted, as shown in Figure 10. Before the capturing 
of the exosomes, the control impedance was measured to be 1.06 k
Ω at 100 Hz. Then the impedance increased to 16.14 kΩ when the 
exosomes were immobilized in between the electrodes. To increase 
the sensitivity of the captured exosomes, the anti-CD63 conjugated 
gold nanoparticles were bound onto the exosomes, and the impedance 
has increased to 19.33 kΩ showing 19.76 % increase as the anti-
CD63 conjugated gold nanoparticles were added. The SEM image of 
before and after the immobilization of the captured exosome and 
bound anti-CD63 conjugated gold nanoparticles are shown in Figure 
11. The results show that the impedance has induced after the 
exosomes were immobilized, and anti-CD63 conjugated gold 
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nanoparticles were bound onto the exosomes. The change in the 
value of the impedance has induced due to the additional double layer 
capacitance (Cg) and the resistance (Rg) that are formed from the 










Figure 10. Impedance measurement of exosomes and anti-CD63 





























Figure 11. Field-emission scanning electron microscope (FE-SEM) 
image. (a) Electrode without exosome. (b, c) Electrode with exosome 









Chapter 4. Conclusion 
 
In this study, an impedance-based biosensor with the application 
of interdigitated electrode has been fabricated. The surface of the 
biosensor was modified to capture human plasma-derived exosomes. 
When human plasma-derived exosomes were loaded onto the sensor, 
it has successfully captured and was able to detect through 
impedance measurement. To further induce the change in impedance, 
an additional binding of surface modified gold nanoparticle was 
applied. The anti-CD63 was conjugated onto the gold nanoparticles 
to specifically bind to the captured exosomes. As the anti-CD63 
conjugated gold nanoparticles were attached to exosomes, it showed 
that the impedance has increased. The application of the conjugated 
gold nanoparticle has induced the change in the impedance, which 
indicates the sensitivity enhancement. Therefore, the proposed 
biosensor shows a promising technique that is capable to further 
expand the detection of exosomes as a diagnostic tool in clinical 
application. In future studies, the detection of various types of 
exosomes derived from cancer and neurodegenerative diseases 
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표면 개질 된 금나노입자를 활용한 
임피던스 기반 세포외소포 검출   
바이오센서 





 세포외소포는 유전자 물질 및 단백질과 같은 생물학적 물질을 함유하며, 
세포 간에 정보 및 전달을 하는 중요한 역할을 가지고 있다. 이러한 
세포외소포가 가지고 있는 특성으로 인하여 다양한 질병을 검출하기 
위한 진단 도구로 사용할 수 있어 많은 관심과 연구가 진행되고 있다. 
그러나, 나노 크기의 작은 세포외소포를 검출하고 분석할 수 있는 
기술에 있어 어려움이 있는데, 현재 세포외소포를 검출 및 분석하기 
위한 기술은 다소 복잡한 실험 절차가 있는 것 뿐만이 아니라 검사하고 
측정하며 결과를 얻기까지의 시간이 길다는 한계점이 있다. 보다 빠른 
분석을 위해, 본 연구에서는 임피던스 측정을 통해 세포외소포를 검출 
및 분석을 하는 깍지형(interdigitated) 전극을 활용한 임피던스 기반 
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바이오센서가 개발되었다. 제작한 임피던스 기반 바이오센서의 감도를 
향상하기 위해 anti-CD63 항체를 복합한 금 나노입자를 세포외소포에 
결합하였다. 이 연구의 결과를 보았을 때, 세포외소포를 검출하기 
전에는 1.055kΩ의 임피던스 값이 나왔는데, 세포외소포를 더하여 
검출하였을 때 임피던스 값이 16.14kΩ으로 측정되어 증가한 것을 볼 
수 있었다. 더 나아가 항체 anti-CD63를 복합한 금 나노입자를 검출한 
세포외소포에 결합하였을 때에는 임피던스 값이 19.33kΩ으로 증가하여 
세포외소포 만 검출하였을 때와 비교하면 19.76%의 임피던스 증가를 
확인할 수 있었다. 본 연구에서 제안된 임피던스 기반 바이오센서 
플랫폼은 세포외소포 검출에 대한 연구 기술 확장이 가능하며, 
임상응용에서 진단도구로 사용될 수 있다.  
 
주요어 : 세포외소포, 엑소좀, 임피던스 기반 센서, 바이오센서, 금나노입
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